Background: Having large face pores is a frequent cosmetic and dermatological issue for many people. Due to its complex pathophysiology and poor influence on patients' quality of life, treatment is challenging. Because of this, reducing the size of face pores is a hot topic in the cosmetics world. Skin rejuvenation, and reduction in sebum production are just a few of the treatment options available for treating facial pores. The effectiveness and safety of any of the presently offered medications or therapies have not been studied in humans in a lot of clinical studies. Hormonal medication, including cyproterone acetate, spironolactone, and combination of oral contraceptives, are among the treatment possibilities in addition to isoretinoin. Medications applied topically, such as L-carnitine, niacinamide at a concentration of 2 percent, tretinoin or tazarotene, glycolic acid and salicylic acid peels, moisturisers, and sunscreens, require formulations free of occlusive, comedogenic, and oil-free substances. Laser diodes, non-ablative radiofrequency technologies, and photodynamic therapy all showed promising results. Objective: To make an overview of updated guidelines for treating wide facial pores. Methods: The databases were searched for articles published in English in 3 data bases [PubMed – Google scholar and Egyptian bank of knowledge] and Boolean operators had been used such as [Wide facial pores AND Novel Treatment OR hair removal] and in reviewed articles. Conclusion: Treatment of enlarged facial pores aims at reducing sebum production and/or reducing folliculler size. The treatment options include oral and topical medication, diet modification, laser, Botulinum toxin  as well as hair removal.